This is the protocol for a review and there is no abstract. The objectives are as follows: To determine whether different platelet transfusion thresholds for administration of prophylactic platelet transfusions (platelet transfusions given to prevent bleeding) affect the efficacy and safety of prophylactic platelet transfusions in preventing bleeding in patients with haematological disorders after chemotherapy with or without stem cell transplantation
Background Bone marrow disorders encompass a group of diseases characterised by reduced production o...
AbstractAn optimal platelet-count threshold for prophylactic platelet transfusion in hematopoietic s...
BACKGROUND: The effectiveness of platelet transfusions to prevent bleeding in patients with hematolo...
This is the protocol for a review and there is no abstract. The objectives are as follows: To deter...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
Background Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
What is the optimal platelet count threshold for prophylactic platelet transfusions to minimize blee...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
Background: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
BACKGROUND: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
This is the protocol for a review and there is no abstract. The objectives are as follows: To deter...
Background Platelet transfusions are used in modern clinical practice to prevent and treat bleeding ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess...
This is the protocol for a review and there is no abstract. The objectives are as follows: To compar...
Background Bone marrow disorders encompass a group of diseases characterised by reduced production o...
AbstractAn optimal platelet-count threshold for prophylactic platelet transfusion in hematopoietic s...
BACKGROUND: The effectiveness of platelet transfusions to prevent bleeding in patients with hematolo...
This is the protocol for a review and there is no abstract. The objectives are as follows: To deter...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
Background Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
What is the optimal platelet count threshold for prophylactic platelet transfusions to minimize blee...
This is the protocol for a review and there is no abstract. The objectives are as follows: To determ...
Background: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
BACKGROUND: Platelet transfusions are used in modern clinical practice to prevent and treat bleeding...
This is the protocol for a review and there is no abstract. The objectives are as follows: To deter...
Background Platelet transfusions are used in modern clinical practice to prevent and treat bleeding ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess...
This is the protocol for a review and there is no abstract. The objectives are as follows: To compar...
Background Bone marrow disorders encompass a group of diseases characterised by reduced production o...
AbstractAn optimal platelet-count threshold for prophylactic platelet transfusion in hematopoietic s...
BACKGROUND: The effectiveness of platelet transfusions to prevent bleeding in patients with hematolo...